[DOI] [PMC free article] [PubMed] [Google Scholar] [12].Black M, Trent A, Tirrell M
Each offers unique benefits based on your weight loss goals
Optogenetic activation of VTA-glutamatergic neurons that project to the NAc leads to aversion by activating GABA interneurons, which in turn release GABA onto medium spiny neurons [47, 48]
A qualitative exploration of patient and staff experiences of the receipt and delivery of specialist weight management services in the UK
While both medications showed a significant weight loss benefit, after 72 weeks on treatment, people treated with Zepbound lost 20% of their body weight, compared to people on Wegovy who lost just under 14%
Both are associated with increased health and decelerated aging markers